SIDP Position Statements
Position statements from the Society of Infectious Diseases Pharmacists can be found on the Policy and Government Affairs page
Guidance Endorsed By SIDP
Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society of Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Guidance for the Knowledge and Skills Required for Antimicrobial Stewardship Leaders
Therapeutic Monitoring of Vancomycin in Adult Patients: a
Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Insights from SIDP
Recommended Revisions to the National SEP-1 Sepsis Quality Measure: A Commentary by the Society of Infectious Diseases Pharmacists on the Infectious Diseases Society of America Position Paper. Heil EL, Aitken SL, Nix DE, et al. Pharmacotherapy. 2020 Apr;40(4):368-371.
Pharmacists Filing the Gap Within Penicillin Allergy Assessment and Skin Testing. Bland CM, Jones BM. Clin Infect Dis. 2020 Jul;ciaa978.
Best Care for Patients Achieved Through Multidisciplinary Stewardship. Dodds Ashley E, Davis SL, Heil EL, et al. Clin Infect Dis. 2018 Oct;67(10):1637.
Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists. Deming P, Martin MT, Chan J, et al. Pharmacotherapy. 2016 Feb;36(2):203-217.
Consensus Summary of Aerosolized Antimicrobial Agents: Application of Guideline Criteria. Insights from the Society of Infectious Diseases Pharmacists. Le J, Ashley ED, Neuhauser MM, et al. Pharmacotherapy. 2010 Jun;30(6):562-584.
Insights from the Society of Infectious Diseases Pharmacists on Antimicrobial Stewardship Guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Drew RH, White R, MacDougall C, et al. Pharmacotherapy. 2009 May;29(5):593-607.
Recommendations for Training and Certification for Pharmacists Practicing, Mentoring, and Educating in Infectious Diseases Pharmacotherapy. Ernst EJ, Klepser ME, Bosso JA. Pharmacotherapy. 2009 Apr;39(4):482-488.
Treatment of Active Pulmonary Tuberculosis in Adults: Current Standards and Recent Advances. Hall RG, Leff RD, Gumbo T. Pharmacotherapy. 2009 Dec;29(12):235-249.
The Current State of Multidrug-Resistant Gram Negative Bacilli in North America. Nicasio AM, Kuti JL, Nicolau DP. Pharmacotherapy. 2008 Feb;28(2):235-249.
Antimicrobial Dosing Considerations in Obese Adult Patients. Pai MP, Bearden DT. Pharmacotherapy. 2007 Aug;27(8):1081-1091.
Application of Antimicrobial Pharmacodynamic Concepts Into Clinical Practice: Focus on Beta-lactam Antibiotics. Lodise TP, Lomaestro BM, Drusano GL. Pharmacotherapy. 2006 Sep;26(9):1320-1332.
Bioterrorism: Pivotal Clinical Issues: Consensus Review of the Society of Infectious Diseases Pharmacists. Terriff CM, Schwartz MD, Lomaestro BM. Pharmacotherapy. 2003 Mar;23(3):274-290.
Society of Infectious Diseases Pharmacists (SIDP) Position Papers. Strayer AH. Pharm Pract Manag Q. 1996;16(2):62-65.